ctrl K

Advertisement

NKGen Biotech Inc. Common... (NKGN)

NASDAQ: NKGN · Real-Time Price · USD

0.17

0.02 (13.33%)

At close: Apr 29, 2025, 2:52 PM

NKGen Biotech Common Stock Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	n/a	77K	426K
Cost of Revenue	1.2M	18K	30K
Gross Profit	-1.2M	59K	396K
Operating Income	-29.75M	-24.35M	-21.86M
Interest Income	n/a	n/a	n/a
Pretax Income	-82.95M	-26.75M	-23.26M
Net Income	-82.95M	-26.75M	-23.27M
Selling & General & Admin	14.08M	7.66M	7.58M
Research & Development	14.46M	16.75M	14.67M
Other Expenses	n/a	-95K	-84K
Operating Expenses	28.54M	24.41M	22.26M
Interest Expense	745K	2.31M	1.31M
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	29.75M	24.42M	22.29M
Income Tax Expense	7K	7K	5K
Shares Outstanding (Basic)	15.43M	6.36M	21.45M
Shares Outstanding (Diluted)	15.43M	6.36M	21.45M
EPS (Basic)	-5.38	-4.21	-1.08
EPS (Diluted)	-5.38	-4.21	-1.08
EBITDA	-28.54M	-23.23M	-20.7M
EBIT	-82.2M	-24.44M	-21.95M
Depreciation & Amortization	1.2M	1.21M	1.24M